Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma.

Xiong, Xiaofeng; Song, Qianben; Jing, Mengjia; Yan, Wei

Xiong, Xiaofeng; Song, Qianben; Jing, Mengjia; Yan, Wei.

Afiliación

Xiong X; Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Song Q; Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jing M; Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yan W; Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Genet Res (Camb) ; 2023: 6879022, 2023.

Article en En | MEDLINE | ID: mdl-37313428

Asunto(s)

Carcinoma Hepatocelular; Quimioembolización Terapéutica; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/tratamiento farmacológico; Carcinoma Hepatocelular/genética; Pronóstico; Sorafenib/uso terapéutico; Neoplasias Hepáticas/tratamiento farmacológico; Neoplasias Hepáticas/genética; Inmunoterapia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Genet Res (Camb) Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google